Home Cart Sign in  
Chemical Structure| 2252262-24-9 Chemical Structure| 2252262-24-9

Structure of Sabatolimab
CAS No.: 2252262-24-9

Chemical Structure| 2252262-24-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sabatolimab is a humanized IgG4 monoclonal antibody that prevents TIM-3 from binding to its ligand. Sabatolimab has potential for research in myelodysplastic syndrome and acute myeloid leukemia.

Synonyms: MBG453

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sabatolimab

CAS No. :2252262-24-9
M.W : 144.9 kDa
SMILES Code : NONE
Synonyms :
MBG453
MDL No. :N/A

Safety of Sabatolimab

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT04823624 Myelodysplastic Syndromes PHASE2 RECRUITING 2026-01-01 Massachusetts General Hospital... More >> Cancer Center, Boston, Massachusetts, 02114, United States|Brigham and Women's Hospital, Boston, Massachusetts, 02215, United States|Dana-Farber Cancer Institute, Boston, Massachusetts, 02215, United States Less <<
NCT03961971 Glioblastoma Multiforme PHASE1 ACTIVE_NOT_RECRUITING 2025-09-25 Stanford University, Stanford,... More >> California, 94305, United States|Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland, 21287, United States Less <<

References

 

Historical Records

Categories